Emergent BioSolutions | Frais De Vente Et D'Administration

Selling And Administration Expenses Changement Date
Acadia Pharmaceuticals USD 111.46M 13.58M 2023-12
ALKERMES USD 167.95M 37.31M 2023-09
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
Amarin USD 45.46M 5.5M 2023-09
ANI Pharmaceuticals USD 44.46M 2.46M 2023-12
Exact Sciences USD 411.03M 20.48M 2023-12
Exelixis USD 138.14M 3.58M 2023-09
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
Ironwood Pharmaceuticals USD 38.67M 2.62M 2023-12
Merck USD 2.75B 272M 2023-12
Moderna USD 470M 28M 2023-12
Myriad Genetics USD 136.7M 600K 2023-12
Neurocrine Biosciences USD 204.2M 17.6M 2023-09
Pacira USD 65.8M 2.15M 2023-12
Pfizer USD 4.47B 1.27B 2023-12
PTC Therapeutics USD 76.29M 4.6M 2023-12
Sarepta Therapeutics USD 120.89M 2.33M 2023-09
United Therapeutics USD 128.6M 1000K 2023-12



Emergent BioSolutions Frais De Vente Et D'Administration - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2024.